Last Updated:
Name Designation Appointment Date Status
Sandeep Kumar Kedia

Appointed as Director since February 2024

 Director 14-Feb-2024 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Pfinext Pharmaceutical Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Amit Kumar Kedia

Appointed as Director since February 2024

 Director 14-Feb-2024 Current
Aman Kedia

Appointed as Director since February 2024

 Director 14-Feb-2024 Current
Rajesh Kumar

Appointed as Director since February 2024

 Director 14-Feb-2024 Current

People Timeline

Explore the timeline of key personnel in Pfinext Pharmaceutical Private Limited's leadership journey.

Contact Details
  • Address 217, Second Floor, Pitam, Pura, Rajdhani Enclave, Delhi Delhi, 110034, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 110034
  • Country India
  • Website -
Frequently Asked Questions
You can contact Pfinext Pharmaceutical Private Limited through their registered address at 217, Second Floor, Pitam, Pura, Rajdhani Enclave, Delhi Delhi, 110034, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Pfinext Pharmaceutical Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • SANDEEP KUMAR KEDIA
  • AMIT KUMAR KEDIA
  • AMAN KEDIA
  • RAJESH KUMAR
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available